Publication
Journal of Human Stress
Vol 4, Issue 2
Abstract
Oxygen consumption is usually considered to be predictable and unalterable at a fixed work intensity. The relaxation response is hypothesized to be an integrated hypothalamic response which results in generalized decreased sympathetic nervous system activity. One physiologic manifestation of the relaxation response is decreased oxygen consumption. The possibility that the elicitation of the relaxation response could decrease oxygen consumption at a fixed work intensity was investigated. Oxygen consumption was decreased 4 percent (p < 0.05) in eight subjects working at a fixed intensity when the relaxation response was simultaneously elicited.
Web and Email Links
Related Listings
Journal
Biofeedback and Self-regulation
The purpose of this study was to assess the central nervous system effects of the relaxation response (RR) in novice subjects using a controlled, within- subjects design and topographic EEG mapping as the dependent measure. Twenty subjects listened to a RR and control audiotape presented in a counterbalanced order while EEG was recorded from 14 scalp locations. The RR condition produced greater (p < .0164) reductions in frontal EEG beta activity relative to the control condition. N […]
Journal
Behavioral Medicine
Over the last 20 years, medical researchers from a variety of disciplines, including behavioral medicine, neuro-immunology, neuroendocrinology, social medicine, and psychiatry, have converged in an effort to produce greater understanding and acceptance of the effects of psychological factors on physical health. Many in the medical profession have remained somewhat skeptical, claiming that psychological components of healing are largely "folklore", unsubstantiated by hard evidence. The […]
Journal
Journal Alternative and Complementary Medicine
Objective: Mind–body practices that elicit the relaxation response (RR) have been demonstrated to reduce blood pressure (BP) in essential hypertension (HTN) and may be an adjunct to antihypertensive drug therapy. However, the molecular mechanisms by which the RR reduces BP remain undefined. Design: Genomic determinants associated with responsiveness to an 8-week RR-based mind–body intervention for lowering HTN in 13 stage 1 hypertensive patients classified as BP responders and 11 as n […]